ArticleJournal of gastrointestinal oncology2026

Intratumoral PKM2 expression predicts benefit from adjuvant FOLFOX in stage II-III colorectal cancer.

Eonwoo Shin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.